[1] Iorio MV, V isone R, Leva G, et al. M icroRNA signatures in human ovarian cancer[J]. Cancer Res, 2007, 67: 8699-8707. [2] Lee RC, Feinbaum RL, Ambros VC, et al. The heterochronic gene Lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75 (5): 843. [3] Mezzanzanica D, Canevari S, Cecco LD,et al. MiRNA control of apoptotic programs: focus on ovarian cancer[J].Expert Rev Mol Diagn,2011,11(3):277-286. [4] Bovicelli A, D'Andrilli G, Giordano A. New players in ovarian cancer [J]. Cell Physiol,2011, 226(10):2500-2504. [5] 刘霞, 代荫梅,张为远.MicroRNA在妇科肿瘤中的研究进展[J].中华医学杂志, 2009,89(5):357-359. [6] Huang Yujing, Ying Qi, Qiang Ruan, et al. A rapid method to screen putative mRNA targets of any known microRNA[J]. Virology Journal,2011, 8:8. [7] Mezzanzanica D, Canevari S, Cecco LD,et al.miRNA control of apoptotic programs: focus on ovarian cancer[J].Expert Rev Mol Diagn,2011,11(3):277-286. [8] Schmeier S, Schaefer U, Essack M,et al. Network analysis of microRNAs and their regulation in human ovarian cancer[J].BMC Syst Biol,2011,5:183-189. [9] Shen J,Dicioccio R,Odunsi K,et al. Novel genetic variants in miR-191 gene and familial ovarian cancer[J].BMC Cancer,2010,10:47-52. [10] Michael MZ, O’Connor SM, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia [J]. Mol Cancer Res, 2003, 1: 882-891. |